Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Inspire Singapore Study

← catalyst calendar

NCT06540716

Sponsored by Inspire Medical Systems, Inc. (industry) · INSP — their whole pipeline →.

Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Na · None · Treatment
Enrollment
44actual
Sites
2
Country
Singapore

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2024-07-25actualWhen the study began enrolling
Primary completion2025-07-17actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2025-12-01actualThe whole study's end, after follow-up
First posted2024-08-06actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-05-22actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Obstructive Sleep Apnea
  • OSA
  • Sleep Apnea

Intervention

  • Device: Inspire System

Primary outcome

what the primary-completion date above is the date OF
Inspiratory Overlap
measured 0-3 months post-therapy activation

Permalink · INSP's whole pipeline · Catalyst calendar · Every registered study · What changed